| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Canada | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Argentina | 1 | |
| #5 | China | 1 | |
| #6 | France | 1 | |
| #7 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Measuring microorganism processes | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tazi Jamal | 16 |
| #2 | Scherrer Didier | 15 |
| #3 | Najman Romain | 14 |
| #4 | Garcel Aude | 11 |
| #5 | Mahuteau Florence | 10 |
| #6 | Campos Noelie | 7 |
| #7 | Mahuteau-Betzer Florence | 3 |
| #8 | Gadea Gilles | 3 |
| #9 | Roux Pierre | 3 |
| #10 | Brock Carsten | 3 |
| Publication | Filing date | Title |
|---|---|---|
| EP2757161A1 | miRNA-124 as a biomarker of viral infection | |
| EP2712862A1 | New anti-invasive compounds | |
| FR2987627A1 | USE OF RBM39 AS A BIOMARKER | |
| EP2266972A1 | New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies |